GeneDx Holdings (WGS) Goodwill (2022 - 2026)

GeneDx Holdings (WGS) posted quarterly Goodwill of $1.6 million for Q1 2026, down 87.86% sequentially from $13.5 million in Q4 2025.

GeneDx Holdings (WGS) Goodwill (2022 - 2026) Analysis & Trends

GeneDx Holdings has disclosed Goodwill across 3 years of filings, most recently posting $1.6 million for Q1 2026.

In Q1 2026, Goodwill changed N/A year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (changed N/A YoY), while the FY2025 annual figure was $13.5 million, changed N/A from the prior year.
Goodwill eased to $1.6 million in Q1 2026, from $13.5 million in the prior quarter.
Over the last five years, Goodwill for WGS reached as high as $181.5 million in Q3 2022 and fell as low as $1.6 million in Q1 2026.
The 3-year median for Goodwill is $13.2 million (2025), against an average of $67.3 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	GeneDx Holdings	2.10 Bn	1.93 Bn	68.21 Mn

Download Data